Cangrelor Tetrasodium

CSCCNC1=C2C (=NC (=N1) SCCC (F) (F) F) N (C=N2) C3C (C (C (O3) COP (=O) ([O-]) OP (=O) (C (P (=O) ([O-]) [O-]) (Cl) Cl) [O-]) O) O.[Na+].[Na+].[Na+].[Na+]

Cangrelor (AR-C69931MX) is a potent, competitive P2Y12 receptor inhibitor that is administered by intravenous infusion and rapidly achieves near complete inhibition of ADP-induced platelet aggregation.